As biopharma anticipates the “Facility of the Future,” a definition of what closed processing is, and quantification of its value, can be helpful information.
Christophe Dufossé
Advertisement
Christophe Dufossé is senior strategic marketing manager Next-Gen Bioprocessing, Merck KGaA, Darmstadt, Germany.
Articles by Christophe Dufossé
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
